| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.38 | 2e-10 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.33 | 1e-07 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.24 | 0.0002 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.14 | 0.04 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.12 | 0.07 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.11 | 0.09 |